JP2012512814A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012512814A5 JP2012512814A5 JP2011541029A JP2011541029A JP2012512814A5 JP 2012512814 A5 JP2012512814 A5 JP 2012512814A5 JP 2011541029 A JP2011541029 A JP 2011541029A JP 2011541029 A JP2011541029 A JP 2011541029A JP 2012512814 A5 JP2012512814 A5 JP 2012512814A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- pharmaceutical composition
- composition according
- antagonist
- csf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13968708P | 2008-12-22 | 2008-12-22 | |
| US61/139,687 | 2008-12-22 | ||
| US16449109P | 2009-03-30 | 2009-03-30 | |
| US61/164,491 | 2009-03-30 | ||
| PCT/AU2009/001671 WO2010071923A1 (en) | 2008-12-22 | 2009-12-21 | Pain treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014138170A Division JP6147704B2 (ja) | 2008-12-22 | 2014-07-04 | 疼痛治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012512814A JP2012512814A (ja) | 2012-06-07 |
| JP2012512814A5 true JP2012512814A5 (https=) | 2013-02-14 |
| JP5674677B2 JP5674677B2 (ja) | 2015-02-25 |
Family
ID=42286785
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011541029A Active JP5674677B2 (ja) | 2008-12-22 | 2009-12-21 | 疼痛治療 |
| JP2014138170A Active JP6147704B2 (ja) | 2008-12-22 | 2014-07-04 | 疼痛治療 |
| JP2017074868A Pending JP2017149740A (ja) | 2008-12-22 | 2017-04-05 | 疼痛治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014138170A Active JP6147704B2 (ja) | 2008-12-22 | 2014-07-04 | 疼痛治療 |
| JP2017074868A Pending JP2017149740A (ja) | 2008-12-22 | 2017-04-05 | 疼痛治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8475796B2 (https=) |
| EP (2) | EP2387418B1 (https=) |
| JP (3) | JP5674677B2 (https=) |
| KR (1) | KR101761324B1 (https=) |
| CN (2) | CN108014335A (https=) |
| AU (2) | AU2009329811B2 (https=) |
| BR (1) | BRPI0918103A2 (https=) |
| CA (1) | CA2747206C (https=) |
| ES (2) | ES2978209T3 (https=) |
| HK (2) | HK1255046A1 (https=) |
| RU (2) | RU2630969C2 (https=) |
| WO (1) | WO2010071923A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102271705A (zh) | 2008-12-22 | 2011-12-07 | 墨尔本大学 | 骨关节炎治疗 |
| CA2747206C (en) * | 2008-12-22 | 2018-04-24 | The University Of Melbourne | Pain treatment |
| MA37946B1 (fr) * | 2012-09-20 | 2018-09-28 | Morphosys Ag | Utilisation d’un anticorps anti-gm-csf pour le traitement de la polyarthrite rhumatoïde |
| KR20210021153A (ko) * | 2012-09-20 | 2021-02-24 | 모르포시스 아게 | 류마티스 관절염에 대한 치료 |
| WO2014068029A1 (en) * | 2012-10-31 | 2014-05-08 | Takeda Gmbh | Lyophilized formulation comprising gm-csf neutralizing compound |
| AR093297A1 (es) | 2012-10-31 | 2015-05-27 | Amgen Res Munich Gmbh | Formulacion liquida que comprende un compuesto neutralizante de gm-csf |
| US20160024200A1 (en) * | 2013-03-14 | 2016-01-28 | John Schrader | Human monoclonal antibodies that neutralize bioactivity of granulocyte macrophage colony-stimulating factor and methods and uses thereof |
| US10745475B2 (en) | 2013-08-30 | 2020-08-18 | Takeda Gmbh | Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics |
| SG11201901789WA (en) | 2016-09-19 | 2019-03-28 | I Mab | Anti-gm-csf antibodies and uses thereof |
| CN107840885B (zh) * | 2016-09-19 | 2020-11-10 | 天境生物科技(上海)有限公司 | Gm-csf抗体及其用途 |
| CN120093288B (zh) * | 2025-05-08 | 2025-07-11 | 中国农业大学烟台研究院 | 一种牲畜生理行为监测方法及系统 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0482086A1 (en) * | 1989-07-14 | 1992-04-29 | Schering Corporation | Antagonists of gm-csf derived from the carboxyl terminus |
| EP0486572B1 (en) | 1989-08-11 | 1998-01-07 | Amrad Corporation Limited | Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| WO1994009149A1 (en) | 1990-08-10 | 1994-04-28 | Amrad Corporation Limited | Monoclonal antibody |
| AU5611394A (en) * | 1992-11-19 | 1994-06-08 | Dana-Farber Cancer Institute | Antibodies for gm-csf receptor and uses thereof |
| ES2176484T3 (es) | 1995-08-18 | 2002-12-01 | Morphosys Ag | Bancos de proteinas/(poli)peptidos. |
| AUPP525198A0 (en) | 1998-08-13 | 1998-09-03 | Medvet Science Pty. Ltd. | Monoclonal antibody inhibitor of GM-CSF, IL-3 and IL-5 and other cytokines and uses thereof |
| US7108852B2 (en) | 2000-03-20 | 2006-09-19 | Warner-Lambert Company Llc | Methods of treating inflammation using antibodies to M-CSF |
| US7455836B2 (en) * | 2000-05-08 | 2008-11-25 | The University Of Melbourne | Method of treatment and agents useful for same |
| SE0102067D0 (sv) * | 2001-06-11 | 2001-06-11 | A & Science Invest Ab | Prevention of neovascularization of intervertebral discs and/or of tissues with local inflammation |
| EP1442132A2 (en) | 2001-10-26 | 2004-08-04 | Novartis AG | Methods for the treatment of osteoarthritis and compositions thereof |
| JP2006500905A (ja) | 2002-02-13 | 2006-01-12 | ルードヴィッヒ インスティテュート フォー キャンサー リサーチ | ヒト化ｇｍ−ｃｓｆ抗体 |
| AU2002950957A0 (en) * | 2002-08-23 | 2002-09-12 | The Walter And Eliza Hall Institute Of Medical Research | A method of treatment and prophylaxis |
| US7569364B2 (en) | 2002-12-24 | 2009-08-04 | Pfizer Inc. | Anti-NGF antibodies and methods using same |
| US20040241755A1 (en) | 2003-06-02 | 2004-12-02 | Pfizer Inc. | Human cell assay to determine effect of sample compounds on Col2 enhancer expression |
| ES2465141T3 (es) | 2004-03-31 | 2014-06-05 | Kazuwa Nakao | Remedio o medicamento preventivo para la artritis |
| ATE435238T1 (de) | 2004-05-05 | 2009-07-15 | Micromet Ag | Herstellung eines einkettigen fv antikörperfragments |
| BRPI0608281B8 (pt) | 2005-04-18 | 2021-05-25 | Amgen Res Munich Gmbh | anticorpo monoclonal humano ou seu fragmento, seu uso no tratamento de doenças inflamatórias, bem como composição farmacêutica que o compreende |
| RU2447085C2 (ru) * | 2005-05-18 | 2012-04-10 | МорфоСис АГ | Анти-gm-csf антитела и их применение |
| JP4736037B2 (ja) | 2005-10-26 | 2011-07-27 | 株式会社イーベック | ヒトｇｍ−ｃｓｆに結合するヒトのモノクローナル抗体並びにその抗原結合部分 |
| EA200801166A1 (ru) | 2005-12-01 | 2008-12-30 | Домантис Лимитед | Форматы конкурентного доменного антитела, которые связываются с рецептором интерлейкина 1 первого типа |
| US7741450B2 (en) | 2006-02-08 | 2010-06-22 | Morphotek Inc. | Antibodies to GM-CSF |
| MX2008012291A (es) | 2006-03-27 | 2009-01-12 | Medimmune Ltd | Miembro que enlaza al receptor gm-csf. |
| US7741273B2 (en) * | 2006-04-13 | 2010-06-22 | Warsaw Orthopedic, Inc. | Drug depot implant designs |
| EP2101780B1 (en) * | 2006-11-21 | 2013-10-09 | Kalobios Pharmaceuticals, Inc. | Methods of treating chronic inflammatory diseases using a gm-csf antagonist |
| WO2008080134A2 (en) | 2006-12-22 | 2008-07-03 | Rigel Pharmaceuticals, Inc. | 4-amin0-2- (hetero) arylamino-5- (hetero) arylthiazoles useful as axl inhibitors |
| CN101687926A (zh) | 2007-05-23 | 2010-03-31 | 哮喘和气道Crc有限公司 | 中和抗体 |
| TW200918553A (en) | 2007-09-18 | 2009-05-01 | Amgen Inc | Human GM-CSF antigen binding proteins |
| WO2009062238A1 (en) | 2007-11-12 | 2009-05-22 | Crc For Asthma And Airways Ltd | Epitope for neutralizing antibodies |
| CN104072613A (zh) | 2007-11-13 | 2014-10-01 | Evec股份有限公司 | 与hGM-CSF结合的单克隆抗体及包含它的药物组合物 |
| WO2009134805A2 (en) | 2008-04-28 | 2009-11-05 | Kalobios Pharmaceuticals, Inc. | Antibodies to granulocyte-macrophage colony-stimulating factor |
| CN102271705A (zh) | 2008-12-22 | 2011-12-07 | 墨尔本大学 | 骨关节炎治疗 |
| CA2747206C (en) * | 2008-12-22 | 2018-04-24 | The University Of Melbourne | Pain treatment |
| US8609101B2 (en) | 2009-04-23 | 2013-12-17 | Theraclone Sciences, Inc. | Granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralizing antibodies |
-
2009
- 2009-12-21 CA CA2747206A patent/CA2747206C/en active Active
- 2009-12-21 AU AU2009329811A patent/AU2009329811B2/en active Active
- 2009-12-21 ES ES18170226T patent/ES2978209T3/es active Active
- 2009-12-21 RU RU2011127333A patent/RU2630969C2/ru active
- 2009-12-21 JP JP2011541029A patent/JP5674677B2/ja active Active
- 2009-12-21 US US13/140,839 patent/US8475796B2/en active Active
- 2009-12-21 CN CN201711112956.0A patent/CN108014335A/zh active Pending
- 2009-12-21 WO PCT/AU2009/001671 patent/WO2010071923A1/en not_active Ceased
- 2009-12-21 EP EP09833923.7A patent/EP2387418B1/en active Active
- 2009-12-21 KR KR1020117017019A patent/KR101761324B1/ko not_active Expired - Fee Related
- 2009-12-21 CN CN200980151639.7A patent/CN102256621B/zh active Active
- 2009-12-21 EP EP18170226.7A patent/EP3381471B1/en active Active
- 2009-12-21 ES ES09833923.7T patent/ES2685895T3/es active Active
- 2009-12-21 BR BRPI0918103A patent/BRPI0918103A2/pt not_active Application Discontinuation
- 2009-12-21 RU RU2016102346A patent/RU2712166C2/ru active
-
2013
- 2013-05-28 US US13/903,009 patent/US9352034B2/en active Active
-
2014
- 2014-07-04 JP JP2014138170A patent/JP6147704B2/ja active Active
-
2016
- 2016-01-18 AU AU2016200267A patent/AU2016200267B2/en active Active
- 2016-04-29 US US15/142,746 patent/US9834599B2/en not_active Expired - Fee Related
-
2017
- 2017-04-05 JP JP2017074868A patent/JP2017149740A/ja active Pending
-
2018
- 2018-11-07 HK HK18114170.3A patent/HK1255046A1/zh unknown
- 2018-11-09 HK HK18114356.9A patent/HK1255227A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012512814A5 (https=) | ||
| JP2009256391A5 (https=) | ||
| CY2017039I1 (el) | Αντισωματα υψηλης συγγενειας στον υποδοχεα της ανθρωπινης ιl-6 | |
| JP2011006431A5 (https=) | ||
| IL227990B (en) | Use of 3-(5-amino-2-methyl-4-oxoquinazolin-3(4h)-yl) piperidine-2,6-dione for preparation of medicaments for treatment of immune-related and inflammatory diseases | |
| CL2007003609A1 (es) | Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion | |
| CR10379A (es) | Composiones farmaceuticas de antagonistas del anticuerpo anti-cd40. | |
| CL2007001993A1 (es) | Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat | |
| IL215579A (en) | Use of 1-benzyl-3-hydroxymethylindazole history to prepare medicinal products for the treatment of diseases based on the expression of 1-mcp, cx3cr1 and 40p | |
| DK2172450T3 (da) | Nye malonsyre- og sulfonamidderivater og farmaceutisk brug deraf. | |
| IL215065A (en) | Proline derivatives, their preparation process, their pharmaceutical compositions and their uses in drug preparation | |
| EA201101190A1 (ru) | Фармацевтическая композиция, включающая линаглиптин и необязательно ингибитор sglt2, и ее применение | |
| IL217052A0 (en) | Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them | |
| SMT201800044T1 (it) | Anticorpi leganti la protofibrilla e loro uso in metodi terapeutici e diagnostici per il morbo di parkinson, la demenza con corpi di lewy e altre alfa-sinucleinopatie | |
| FR2941696B1 (fr) | Derives d'azaspiranyl-alkylcarbamates d'heterocycles a 5 chainons, leur preparation et leur application en therapeutique | |
| FR2962437B1 (fr) | Derives d'imidazopyridine, leur procede de preparation et leur application en therapeutique | |
| CL2013001943A1 (es) | Uso de un agonista opioide y un antagonista opioide para preparar una forma farmaceutica para el tratamiento de la enfermedad de parkinson y/o al menos un sintoma de la misma. | |
| RU2016102346A (ru) | Лечение боли | |
| LT3135672T (lt) | Kompozicijos ir būdai skirti gydyti alkoholio vartojimo sutrikimus, skausmą ir kitas ligas | |
| IL225290A0 (en) | Cervical pillow for treatment of cervical spine diseases | |
| EA201290032A1 (ru) | Синтез и применение вилдаглиптина для получения лекарственных форм | |
| IL237554B (en) | A pharmaceutical preparation containing an antibody against gm-CSF for the treatment of a patient suffering from rheumatoid arthritis | |
| JP2012512815A5 (https=) | ||
| BR112012003280A2 (pt) | composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto. | |
| EP2171592A4 (en) | PARALLELIZATION OF SEQUENCIAL FRAMEWORK CONDITIONS USING TRANSACTIONS |